Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Verified Innovative Testing in American Laboratories Act of 2021 or the VITAL Act of 2021 This bill expressly shifts the regulation of laboratory-developed testing procedures from the Food and Drug Administration (FDA) to the Centers for Medicare & Medicaid Services (CMS). Under current law, the FDA regulates the safety and effectiveness, as well as quality of design and manufacture, of laboratory-developed tests, while the CMS regulates clinical laboratories and testing processes. Historically, the FDA has exercised enforcement discretion and not enforced certain statutory and regulatory requirements with respect to these tests. The CMS must hold a public meeting to solicit recommendations to update existing regulations related to clinical laboratories, and the Department of Health and Human Services must report specified information to Congress, including an assessment of the availability and use of laboratory-developed testing procedures during the COVID-19 (i.e., coronavirus disease 2019) response.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2022 · second_quarter · Medical/Disease Research/Clinical Labs
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Client expense: Not reported · Firm income: $63,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021 HR2503 Social Determinants Accelerator Act HR. 379 - Improving Social Determinants of Health Act of 2021 S 3506 The Strengthening the Public Health Workforce Act HR 6578 Public Health Workforce Loan Repayment Act HR 6000 Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act HR7585 - Health Equity and Accountability Act of 2022 Patent Reform FDA Safety and Landmark Advancements (FDASLA) Act Right Drug Dose Now (Right) Act PREVENT Pandemics Act HR5602 - BIO Preparedness Workforce Act of 2021 Consolidated Appropriations Act of 2023 PREVENT Pandemics Act (S. 3799) S.5194 - Protecting Medicare Patients and Physicians Act S 5033 - Patrick Leahy and Orrin G. Hatch Justice For All Act of 2022 S 5029 - Help Find the Missing Act S 5230 - Billys Law
Client expense: $111,309 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021; S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation S.1666, VITAL Act of 2021, Diagnostic Lab Testing H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation S.1666, VITAL Act of 2021, Diagnostic Lab Testing H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
Support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for in vitro laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act Laboratory testing for Mpox
Client expense: Not reported · Firm income: $42,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021 HR2503 Social Determinants Accelerator Act HR. 379 - Improving Social Determinants of Health Act of 2021 S 3506 The Strengthening the Public Health Workforce Act HR 5376 Build Back Better Act HR 6578 Public Health Workforce Loan Repayment Act HR 6000 Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act HR7585 - Health Equity and Accountability Act of 2022 Patent Reform FDA Safety and Landmark Advancements (FDASLA) Act Right Drug Dose Now (Right) Act PREVENT Pandemics Act HR5602 - BIO Preparedness Workforce Act of 2021
Client expense: $145,277 · Firm income: Not reported
2022 · third_quarter · Health Issues
Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021; S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for in vitro laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Client expense: Not reported · Firm income: $42,000
Government targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021; S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021 HR2503 Social Determinants Accelerator Act HR. 379 - Improving Social Determinants of Health Act of 2021 S 3506 The Strengthening the Public Health Workforce Act HR 5376 Build Back Better Act HR 6578 Public Health Workforce Loan Repayment Act HR 6000 Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act HR7585 - Health Equity and Accountability Act of 2022 Patent Reform FDA Safety and Landmark Advancements (FDASLA) Act Right Drug Dose Now (Right) Act PREVENT Pandemics Act HR5602 - BIO Preparedness Workforce Act of 2021
Client expense: $86,763 · Firm income: Not reported
2022 · second_quarter · Health Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medical/Disease Research/Clinical Labs
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act S.4348 - FDASLA Act of 2022
Client expense: Not reported · Firm income: $63,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues S.1666, VITAL Act of 2021, Diagnostic Lab Testing Monitor the following: H.R.6000, CURES 2.0, Diagnostic Lab Testing issues Highly skilled visa related issues Public Law 117-58, Infrastructure Investment and Jobs Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · first_quarter · Health Issues
Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; and H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021 HR2503 Social Determinants Accelerator Act HR. 379 - Improving Social Determinants of Health Act of 2021 S 3506 The Strengthening the Public Health Workforce Act HR 5376 Build Back Better Act HR 6578 Public Health Workforce Loan Repayment Act HR 6000 Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Client expense: $121,540 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Health and Human Services Appropriations - In support of funding for the National Institutes of Health, Area Health Education Centers Program, and Health Resources and Services Administration Title VII programs. In support of funding for Regional Response Health Collaboration Program. In support of Community Project Funding request for Mobile Community Medical Unit with medical and dental services to underrepresented populations. In support of extension for 340B program and opposition to proposal to reduce Medicare Part B payments for drugs acquired through 340B program. In support of protection of 340B eligibility in future supplemental funding bills. In support of S.1666, the Verified Innovative Testing in American Laboratories Act.
Client expense: $110,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
HR 5376 Build Back Better Act HR 6578 Public Health Workforce Loan Repayment Act HR 6000 Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Client expense: $110,671 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act NIH/FDA Request for Information on tools for next generation sequencing
Client expense: Not reported · Firm income: $42,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
Health and Human Services Appropriations - In support of funding for the National Institutes of Health, Area Health Education Centers Program, and Health Resources and Services Administration Title VII programs. In support of funding for Regional Response Health Collaboration Program. In support of Community Project Funding request for Mobile Community Medical Unit with medical and dental services to underrepresented populations. In support of extension for 340B program and opposition to proposal to reduce Medicare Part B payments for drugs acquired through 340B program. In support of protection of 340B eligibility in future supplemental funding bills. In support of S.1666, the Verified Innovative Testing in American Laboratories Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128; support initiatives to improve clinical laboratory testing supply chains.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
HR 6578 Public Health Workforce Loan Repayment Act Cures 2.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Client expense: $113,175 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
AACC met House and Senate staff to express opposition to H.R.4128 & S.2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, which would extend Food and Drug Administration oversight to laboratory developed tests (LDTs). AACC joined with other healthcare groups in supporting S.1666, the Verified Innovative Testing in American Laboratories (VITAL) Act, which would codify the existing regulatory model for overseeing LDTs.
Client expense: $90,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
HR 6578 Public Health Workforce Loan Repayment Act Cures 20.0 HR 1868 - to prevent across-the-board direct spending cuts and other purposes HR 1319 - American Rescue Plan Act Paul Coverdell Forensic Science Grant Program S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021 The Health Workforce Resilience Act Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas CLIA Waiver HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Client expense: $115,673 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S 1666, Verified Innovative Testing in American Laboratories (VITAL) Act
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128; support initiatives to improve clinical laboratory testing supply chains.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE